ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,056.37
-0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Biopharma Credit Plc (BPCP) Quote

Biopharma Credit Plc

Biopharma Credit Plc (BPCP)

Bishop Capital Corporation New (CE)
68.80
0.00
(0.00%)
Closed January 05 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
68.80
Bid
66.80
Ask
70.80
Volume
8,591
0.00 Day's Range 0.00
65.20 52 Week Range 76.00
Market Cap
822.079M
Previous Close
68.80
Open
-
Last Trade
14
@
70.6
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
23,305
Shares Outstanding
1,194,882,668
Dividend Yield
-
PE Ratio
9.58
Earnings Per Share (EPS)
0.09
Revenue
135.74M
Net Profit
108.45M

About Biopharma Credit Plc

Sector
Finance Services
Industry
Finance Services
Headquarters
London, Ontario, Can
Founded
-
Biopharma Credit Plc is listed in the Finance Services sector of the London Stock Exchange with ticker BPCP. The last closing price for Biopharma Credit was 68.80p. Over the last year, Biopharma Credit shares have traded in a share price range of 65.20p to 76.00p.

Biopharma Credit currently has 1,194,882,668 shares outstanding. The market capitalization of Biopharma Credit is £822.08 million. Biopharma Credit has a price to earnings ratio (PE ratio) of 9.58.

Ask ADVFN Intelligence (AI)

BPCP Latest News

More News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 24 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 24 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 23 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 23 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 22 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 22 2024
UK Regulatory

BioPharma Credit PLC Director/PDMR Shareholding

BioPharma Credit PLC 22 January 2024 BIOPHARMA CREDIT PLC Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them 1. Details of...

January 22 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 19 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 19 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 18 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 18 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 17 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 17 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 16 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 16 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 15 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 15 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 12 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

January 12 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10068.870.868.81467968.8DE
4-1-1.4326647564569.870.8681860369.13070056DE
121.72.5335320417367.171.1662330568.36449678DE
261.82.686567164186774.2662770068.36523802DE
52-2.2-3.0985915493717665.22010568.7483888DE
156-4-5.4945054945172.888.865.22165174.7040409DE
260-3.7-5.1034482758672.588.865.22041874.64249489DE

BPCP - Frequently Asked Questions (FAQ)

What is the current Biopharma Credit share price?
The current share price of Biopharma Credit is 68.80p
How many Biopharma Credit shares are in issue?
Biopharma Credit has 1,194,882,668 shares in issue
What is the market cap of Biopharma Credit?
The market capitalisation of Biopharma Credit is GBP 822.08M
What is the 1 year trading range for Biopharma Credit share price?
Biopharma Credit has traded in the range of 65.20p to 76.00p during the past year
What is the PE ratio of Biopharma Credit?
The price to earnings ratio of Biopharma Credit is 9.58
What is the cash to sales ratio of Biopharma Credit?
The cash to sales ratio of Biopharma Credit is 7.66
What is the reporting currency for Biopharma Credit?
Biopharma Credit reports financial results in USD
What is the latest annual turnover for Biopharma Credit?
The latest annual turnover of Biopharma Credit is USD 135.74M
What is the latest annual profit for Biopharma Credit?
The latest annual profit of Biopharma Credit is USD 108.45M
What is the registered address of Biopharma Credit?
The registered address for Biopharma Credit is LINK COMPANY MATTERS LIMITED, 6TH FLOOR, GRESHAM STREET, LONDON, ONTARIO, EC2V 7NQ
Which industry sector does Biopharma Credit operate in?
Biopharma Credit operates in the FINANCE SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
MRJ25 MRJ25 1 minute ago
It would be illegal to sell the warrants to the public. But the government could sell the warrants back to the companies. After all they paid a measly 72000 dollars for them.
FNMA
jimr1717 jimr1717 2 minutes ago
“ Moreover, and as noted below, our shares are currently traded on the OTC Pink (OTCQB tier)”

What a blatant Fraud!

Only a Fool would own shares.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318728068&type=HTML&symbol=ATMH&cdn=ef
ATMH
John Doe 2024 John Doe 2024 2 minutes ago
It's a good sign to see share price crawling back up even though it's slow but we need transparency from management and most importantly volume which we are severely lacking.
XERI
JPetroInc JPetroInc 2 minutes ago
T-8's Will Tynan - SRM's Crunchbase search

https://www.crunchbase.com/recently-viewed

imagizer.imageshack.com/v2/1600x1200q70/922/E9k7kO.jpg

OEM
SRM
EarningsCentral EarningsCentral 2 minutes ago
NKE
RiddleKnight53 RiddleKnight53 3 minutes ago
Fred Winocur, Sears attorney could be Denver’s worst criminal defense lawyer. After investigating the facts of his particular case it seems attorney Fred Winocur at Ridley McGreevy & Winocur completely failed at fulfilling his constitutional duty. His failure to provide even the most basic of invest
FSPM
learningcurve2020 learningcurve2020 3 minutes ago
🤷🏻‍♂️
NWBO
cantwate cantwate 3 minutes ago
Remember this email from a long in 2022? Well 6/2025 will be 3 years. Lets see what happens.
Leo Ehrlich
From:leo@ipharminc.com
To:xxxxx

Thu, Jun 16, 2022 at 11:25 AM

Hi xxxx,

The 510k route of the approvals we are seeking should tak
IPIX
learningcurve2020 learningcurve2020 4 minutes ago
🤷🏻‍♂️
NWBO
flipper44 flipper44 4 minutes ago
There is no such thing as a free lunch.

You can’t always get what you want, but if you try some times, you get what you need.

And most importantly, you must have the capacity to give in order to receive, and this requires trust built on met conditions designed in a bull
NWBO
skitahoe skitahoe 4 minutes ago
I believe that most of the longs do post what they believe is possible. The bashers on the other hand post whatever they think will create doubt, even if they know it's totally untrue.

I can't say if any particular basher is short themselves, or working for a boiler room where someon
NWBO
RickNagra RickNagra 5 minutes ago
https://www.barrons.com/articles/fannie-mae-stock-freddie-mac-fnma-privatization-db92f622
FNMA
mr34 mr34 5 minutes ago
It’s extremely concerning that the CEO is publicly admitting that he doesn’t know why “the street” isn’t catching on to this “story”. Expectations have been raised ever since he started talking Dividends and still nothing to show for it.
SDRC
Jawesomel Jawesomel 5 minutes ago
Any dilution is generally bad dilution.....in my opinion. By the way, has anyone seen any filings by LUVU on a change in management or possible buyout?
LUVU
jcromeenes jcromeenes 5 minutes ago
Wouldn't that also mean Freddie needs to sell more shares than Fannie to recap? More dilution than Fannie from here.
FNMA
Zorax Zorax 6 minutes ago
That's pretty slick of Zelenskyy, as he knows nato isn't going to accept Ukraine for years. So, he puts it on pukey. And I'm pretty sure it was Zlenskyy who halted the gas.

"Volodymyr Zelenskyy suggests Ukraine would give up Russian-occupied territory for NATO membership""
DewDiligence DewDiligence 6 minutes ago
Perhaps what you want, IDK. No, that is certainly not the outcome I want. My point in the second paragraph of #msg-175618625 is that ENTA’s cash break-up value including monetization of Mavyret royalties is more than 3x the current share price. Buyout interest in a strictly financial transaction can
ENTA
Mother Lode Mother Lode 6 minutes ago
this is almost comical. What's next Honeywell is buying this dog?
BBANBOB BBANBOB 6 minutes ago
SORRY TO SHALLOW or TOO DEEP NOT SURE WHICH but have fun with yourself putting this stuff out
joe botts joe botts 6 minutes ago
Expert market, CE stocks, Pink limited have come back. REVOKED is a completely different story.
ali g ali g 7 minutes ago
Nixon is the king of Omerta... 
mascale mascale 7 minutes ago
Credential deficiencies and capabilities apply to freecs poster, posting on its own.
HIRU
Biotech_Tradez Biotech_Tradez 7 minutes ago
LOL, trying too hard to fish for suckers!
ENDV
Jawesomel Jawesomel 8 minutes ago
AVXL ! I hope the data is real and this recent gain is going to hold. By the way, has anyone seen any filings by LUVU on a change in management or possible buyout?
AVXL LUVU
BBANBOB BBANBOB 8 minutes ago
TISK TISK

Your Recent History

LSE
BPCP
Biopharma Credit
EU
ORAP
Orapi
BIT
F23738
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads